Pharmaceutical Excipients Market Poised for Significant Growth Amid Rising Drug Innovation and Expanding Global Demand, Reports The Insight Partners

According to The Insight Partners – The global pharmaceutical excipients market is on a robust upward trajectory, and a comprehensive analysis by The Insight Partners lays out the scale of that opportunity. The market is expected to reach US$12.25 billion by 2028, growing from a value of US$7.83 billion in 2021, at a compound annual growth rate (CAGR) of 6.6% over the forecast period.

What Are Pharmaceutical Excipients?

Pharmaceutical excipients are the inactive substances that serve as carriers or vehicles for active pharmaceutical ingredients (APIs). While they may be inert on their own, their role in ensuring drug safety, stability, and efficacy is anything but passive. They enable proper drug delivery, improve shelf life, enhance patient compliance, and support manufacturing efficiency — making them indispensable to modern pharmaceuticals.

Key Market Drivers

One of the primary forces propelling market growth is the surge in product approvals and launches globally. Formulation scientists have recognized that single-component excipients often fail to provide sufficient performance for certain APIs, prompting a focus on co-processed and multifunctional excipients. These next-generation excipients combine two or more existing components at the sub-particle level, offering improved performance while minimizing individual drawbacks.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003534

Co-processed excipients improve drug flow, disintegration, lubrication, and compressibility, while also simplifying formulation processes and making them more cost-effective. They are increasingly being used to replace complex, labor-intensive methods like wet granulation with faster direct-compression processes — without compromising end-product quality.

A notable example of this innovation trend: in July 2021, DFE Pharma launched Pharmacel sMCC 90, a co-processed silicified microcrystalline cellulose developed as a synergistic solution for challenging oral solid dosage formulations.

Regional Highlights: Asia Pacific Leading Growth

Asia Pacific emerged as the fastest-growing regional market in 2021, driven by the growing interest of major global players in developing countries and the desire to outsource excipient manufacturing to the region due to lower labor and production costs. China, in particular, stands as a manufacturing powerhouse. According to the World Health Organization, approximately 400 pharmaceutical excipient manufacturers operate in China, with around 23% specializing exclusively in excipient production. Companies like Colorcon, Roquette, and Meggle have established joint ventures and wholly owned entities in China, underscoring the region’s strategic importance.

Application Insights: Oral Formulations Lead

Among all applications, the oral formulations and tablets segment held the largest market share in 2021, a position it is expected to maintain through the forecast period. Tablets remain the most widely used dosage form globally, incorporating a broad range of excipients including diluents, binders, lubricants, glidants, and super-disintegrants. The segment’s dominance reflects the continued preference among patients and healthcare providers for oral drug delivery.

Segmentation Overview

The market is broadly segmented by type, functionality, clinical indication, application, end user, and geography. By type, the inorganic chemicals segment held the largest share in 2021. By end user, the pharma industries segment leads, followed by biopharma and animal health. Functionality categories span everything from coloring and coating agents to preservatives and controlled-release excipients.

Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00003534

Competitive Landscape

Key players operating in the market include JRS Pharma, Roquette Frères, BASF SE, Evonik Industries, Ashland Inc., Archer-Daniels-Midland Co., The Dow Chemical Co., The Lubrizol Corp., Avantor Inc., MEGGLE GmbH, and Univar Solutions. These companies compete through product innovation, geographic expansion, and technological advancement.

Outlook

The pharmaceutical excipients market is positioned for sustained expansion as the global pharmaceutical industry grows, generic drug production accelerates, and demand for advanced drug delivery systems intensifies. Innovation in co-processed and multifunctional excipients will remain a defining theme, creating new opportunities for manufacturers worldwide well into 2028 and beyond.

Related Reports @

Excipients Market Key Companies, Supply, Demand, and SWOT Analysis by 2031

Sugar Based Excipients Market Share, Size, Trends, and Forecast by 2031

Pharmaceutical Suppositories Market Dynamics and Developments by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.